Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars

Christine Berndt Previously Headed Biosimilar Development Programs At Sandoz

 
• By Dave Wallace

Stada has announced the appointment of former Sandoz executive Christine Berndt as head of global development for specialty and biosimilar products, replacing Michael Mack.

Wooden blocks leader selected chosen people put forward
Christine Berndt will be head of global development for specialty/biosimilar drugs at Stada • Source: Paradee Kietsirikul / Alamy Stock Photo

More from Leadership

More from Generics Bulletin